Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 2349 | 41.095 |
09:34 ET | 200 | 41.53 |
09:39 ET | 2670 | 41.83 |
09:41 ET | 815 | 42.0791 |
09:43 ET | 350 | 41.98 |
09:45 ET | 1765 | 41.495 |
09:48 ET | 600 | 41.505 |
09:50 ET | 1455 | 41.495 |
09:52 ET | 600 | 41.37 |
09:54 ET | 220 | 41.3 |
09:56 ET | 240 | 41.27 |
09:57 ET | 300 | 41.27 |
10:01 ET | 3500 | 41.53 |
10:03 ET | 400 | 41.37 |
10:08 ET | 100 | 41.355 |
10:10 ET | 220 | 41.4 |
10:12 ET | 440 | 41.2 |
10:15 ET | 320 | 41.48 |
10:17 ET | 100 | 41.5 |
10:19 ET | 200 | 41.48 |
10:21 ET | 200 | 41.51 |
10:24 ET | 120 | 41.515 |
10:26 ET | 600 | 41.37 |
10:30 ET | 120 | 41.405 |
10:33 ET | 800 | 41.24 |
10:35 ET | 100 | 41.24 |
10:37 ET | 700 | 41.4 |
10:39 ET | 240 | 41.46 |
10:44 ET | 410 | 41.49 |
10:46 ET | 100 | 41.56 |
10:48 ET | 880 | 41.44 |
10:50 ET | 300 | 41.42 |
10:51 ET | 520 | 41.55 |
10:53 ET | 925 | 41.58 |
10:55 ET | 100 | 41.56 |
10:57 ET | 200 | 41.56 |
11:00 ET | 300 | 41.52 |
11:02 ET | 300 | 41.605 |
11:04 ET | 100 | 41.6 |
11:06 ET | 600 | 41.56 |
11:08 ET | 200 | 41.58 |
11:13 ET | 100 | 41.675 |
11:15 ET | 554 | 41.65 |
11:22 ET | 400 | 41.53 |
11:24 ET | 100 | 41.46 |
11:26 ET | 100 | 41.44 |
11:31 ET | 200 | 41.42 |
11:36 ET | 100 | 41.53 |
11:38 ET | 300 | 41.56 |
11:40 ET | 426 | 41.5 |
11:47 ET | 420 | 41.46 |
11:49 ET | 100 | 41.54 |
11:51 ET | 200 | 41.38 |
11:56 ET | 300 | 41.44 |
11:58 ET | 200 | 41.37 |
12:00 ET | 100 | 41.405 |
12:02 ET | 300 | 41.47 |
12:03 ET | 100 | 41.5 |
12:05 ET | 100 | 41.56 |
12:07 ET | 200 | 41.57 |
12:12 ET | 200 | 41.5 |
12:14 ET | 180 | 41.51 |
12:16 ET | 420 | 41.505 |
12:18 ET | 700 | 41.57 |
12:20 ET | 300 | 41.63 |
12:21 ET | 160 | 41.575 |
12:23 ET | 200 | 41.62 |
12:25 ET | 1200 | 41.465 |
12:27 ET | 100 | 41.48 |
12:30 ET | 120 | 41.49 |
12:32 ET | 401 | 41.47 |
12:34 ET | 200 | 41.4325 |
12:38 ET | 100 | 41.43 |
12:41 ET | 897 | 41.46 |
12:43 ET | 320 | 41.42 |
12:45 ET | 513 | 41.5 |
12:48 ET | 200 | 41.57 |
12:50 ET | 100 | 41.55 |
12:52 ET | 472 | 41.59 |
12:54 ET | 600 | 41.46 |
12:56 ET | 100 | 41.41 |
12:57 ET | 100 | 41.465 |
12:59 ET | 320 | 41.41 |
01:01 ET | 820 | 41.46 |
01:03 ET | 100 | 41.38 |
01:06 ET | 400 | 41.46 |
01:08 ET | 300 | 41.445 |
01:10 ET | 620 | 41.53 |
01:12 ET | 1300 | 41.545 |
01:14 ET | 330 | 41.545 |
01:15 ET | 600 | 41.63 |
01:17 ET | 360 | 41.62 |
01:19 ET | 520 | 41.72 |
01:21 ET | 2615 | 41.735 |
01:24 ET | 110 | 41.6789 |
01:26 ET | 400 | 41.735 |
01:28 ET | 402 | 41.73 |
01:30 ET | 1600 | 41.73 |
01:32 ET | 5617 | 41.725 |
01:33 ET | 3667 | 42 |
01:35 ET | 2095 | 41.865 |
01:37 ET | 200 | 41.85 |
01:39 ET | 1059 | 41.63 |
01:42 ET | 690 | 41.69 |
01:44 ET | 1200 | 41.61 |
01:46 ET | 420 | 41.51 |
01:48 ET | 600 | 41.455 |
01:50 ET | 200 | 41.39 |
01:51 ET | 300 | 41.33 |
01:53 ET | 300 | 41.33 |
01:55 ET | 320 | 41.39 |
02:00 ET | 100 | 41.4 |
02:02 ET | 200 | 41.32 |
02:04 ET | 800 | 41.4 |
02:08 ET | 100 | 41.34 |
02:09 ET | 200 | 41.37 |
02:11 ET | 300 | 41.385 |
02:13 ET | 200 | 41.41 |
02:18 ET | 100 | 41.41 |
02:20 ET | 1500 | 41.38 |
02:24 ET | 854 | 41.46 |
02:26 ET | 1000 | 41.42 |
02:27 ET | 401 | 41.49 |
02:31 ET | 297 | 41.48 |
02:33 ET | 300 | 41.45 |
02:36 ET | 620 | 41.41 |
02:38 ET | 300 | 41.43 |
02:42 ET | 100 | 41.455 |
02:44 ET | 516 | 41.53 |
02:45 ET | 100 | 41.56 |
02:47 ET | 912 | 41.45 |
02:49 ET | 200 | 41.5 |
02:54 ET | 500 | 41.505 |
02:56 ET | 200 | 41.5 |
02:58 ET | 904 | 41.54 |
03:00 ET | 22820 | 41.32 |
03:02 ET | 800 | 41.48 |
03:03 ET | 300 | 41.54 |
03:05 ET | 100 | 41.51 |
03:07 ET | 789 | 41.58 |
03:09 ET | 500 | 41.67 |
03:12 ET | 400 | 41.625 |
03:14 ET | 1320 | 41.56 |
03:16 ET | 500 | 41.51 |
03:21 ET | 1645 | 41.57 |
03:23 ET | 900 | 41.61 |
03:25 ET | 2200 | 41.55 |
03:27 ET | 675 | 41.535 |
03:30 ET | 100 | 41.53 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.3B | -6.4x | --- |
Janux Therapeutics Inc | 2.3B | -49.2x | --- |
IDEAYA Biosciences Inc | 2.5B | -13.6x | --- |
SpringWorks Therapeutics Inc | 2.4B | -7.4x | --- |
Immunitybio Inc | 2.4B | -3.7x | --- |
Keros Therapeutics Inc | 2.2B | -11.9x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
---|---|
Revenue (TTM) | $31.3M |
Shares Outstanding | 56.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.76 |
EPS | $-6.49 |
Book Value | $14.50 |
P/E Ratio | -6.4x |
Price/Sales (TTM) | 73.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,293.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.